| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 323 |
| 1 | PANTOPRAZOLE | 264 |
| 2 | PREDNISONE | 238 |
| 3 | FUROSEMIDE | 233 |
| 4 | ASPIRIN | 228 |
| 5 | METHOTREXATE SODIUM | 226 |
| 6 | ASPIRIN 325 MG | 225 |
| 7 | ASPIRIN 81 MG | 225 |
| 8 | METHOTREXATE | 196 |
| 9 | DEXAMETHASONE | 178 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOZOCIN | 7 | 0.0304 |
| 1 | ALITRETINOIN | 2 | 0.0168 |
| 2 | CALASPARGASE PEGOL | 10 | 0.0124 |
| 3 | TOLCAPONE | 4 | 0.0114 |
| 4 | L DOPA | 3 | 0.0112 |
| 5 | STREPTOMYCIN | 11 | 0.0096 |
| 6 | RALTEGRAVIR | 46 | 0.0088 |
| 7 | DAUNORUBICIN HYDROCHLORIDE | 14 | 0.0085 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 71 | 0.0085 |
| 9 | PIMOZIDE | 4 | 0.0083 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 671 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 456 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 452 |
| 3 | Kinase Inhibitor [EPC] | 380 |
| 4 | Platinum-based Drug [EPC] | 330 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 327 |
| 6 | Loop Diuretic [EPC] | 293 |
| 7 | Benzodiazepine [EPC] | 274 |
| 8 | Opioid Agonist [EPC] | 273 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 230 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 9 | 0.0089 |
| 1 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 452 | 0.0046 |
| 3 | Enzyme Stabilizer [EPC] | 4 | 0.0034 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 11 | 0.0034 |
| 5 | Provitamin D2 Compound [EPC] | 95 | 0.0032 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 76 | 0.0032 |
| 7 | Antimycobacterial [EPC] | 66 | 0.0027 |
| 8 | Protease Inhibitor [EPC] | 117 | 0.0026 |
| 9 | Somatostatin Analog [EPC] | 18 | 0.0026 |